A new e-health model of care for management of chronic disease: determining safety, efficacy and satisfaction to patients and health care providers

Not Applicable

Completed

• Conditions: Hepatitis C Infection; Infection - Other infectious diseases; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Public Health - Health service research

• Registration Number: ACTRN12617000340336
• Lead Sponsor: Royal Adelaide Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-03-03
• Study Completion: 2020-08-30
• Last Update Posted: 16 March 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 307

Inclusion Criteria

PATIENTS:
Aged 18-85 years old
Those with the ability to consent
Patients with CHC that requires ongoing follow-up by a Specialist
Those with access to internet
Patients with the ability to converse adequately in spoken and written English.
CHC patients commencing therapy or currently receiving ongoing monitoring and/or therapy
PRISONERS:
Current incarceration
CHC patients commencing therapy or currently receiving ongoing monitoring and/or therapy
GENERAL PRACTITIONERS OR COMMUNITY NURSES:
Correctional medical officers engaged in management of Viral Hepatitis with Hepatologists OR General practitioners who currently co-manage complex Specialist patients
OR Nurses working in outreach/nurse-led community hepatitis C
Special interest in HCV or liver patients
S100 prescribers

Exclusion Criteria

Patient or their GP with limited or no access to internet
Unable to converse through typing, either due to language barrier or physical disability

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sustained Virological Response at 12-weeks post treatment completion (SVR12) measured by Hepatitis C RNA blood test. [Measured at minimum 12-weeks post completion of treatment. Follow-up to continue until minimum six-months post treatment. ];Treatment initiation rate per practitioner (number of treatments initiated per month) measured by number of assessments entered on the HealthElink system per month enrolled in the system as assessed at the conclusion of the study. [End of study (12 months from recruitment)]

Secondary Outcome Measures

Name	Time	Method
ser satisfaction measured as assessed on post-study questionnaire. Questionnaire designed specifically for this study with ten likert scale based satisfaction questions. [End of study (12 months from recruitment)];Change in clinician confidence in treating hepatitis C as measured on pre and post study questionnaire designed specifically for this study. Ordinal scale (1-10) asking self-reported confidence in Hepatitis C treatment. [Measured prior at time of GP/nurse enrolment and again at the conclusion of the study. ]